
SentiSense
Ctrl+K
Quick tip: Press
to search stocks
D
DGX
Quest Diagnostics Incorporated
$199.21
-4.77 (-2.34%)
Summary
Stories
News
Metrics
Fundamentals
Current Market Valuation
Current Price
$199.21
Live market price
P/E (TTM)
22.77
EPS: $8.75
P/S (TTM)
1.98
Price to Sales
TTM Quarters
4
Quarters included in TTM
Updated: 3/8/2026, 5:51:13 AM
Historical Trends
Range:
Revenue Over Time
Net Income Over Time
Short Interest (% of Float) Over Time
Short Interest
4.8M
% of Float
4.4%
Days to Cover
3.3
Avg Daily Vol
1.5M
Historical income statement data up to 5 years
Historical SEC Filings
Report Period
Debt/Equity
0.79
Leverage ratio
ROE (TTM)
14.52%
Return on equity
Income Statement
Revenue
$11.04B
Cost of Revenue
$7.37B
Gross Profit
$3.67B
Operating Income
$1.56B
Net Income
$1.05B
EPS (Quarter)
$8.75
EPS (TTM)
--
Balance Sheet
Total Assets
$16.23B
Total Liabilities
$8.94B
Shareholders' Equity
$7.21B
Current Assets
$2.38B
Current Liabilities
$2.28B
Cash & Equivalents
--
Long-Term Debt
$5.67B
Cash Flow
Operating Cash Flow
$1.89B
Investing Cash Flow
$-631.00M
Financing Cash Flow
$-1.39B
Free Cash Flow
$1.25B
Profitability Margins
Gross Margin
33.21%
Operating Margin
14.10%
Net Profit Margin
9.48%
ROA (TTM)
6.45%
ROE (TTM)
14.52%
Data source: Polygon.io
Last updated: 3/8/2026, 5:51:16 AM
Company Profile
Symbol
DGX
Market Cap
$21.89B
IPO Date
Dec 17, 1996
CEO
--
Employees
56,000
Sector
--
Industry
SERVICES-MEDICAL LABORATORIES
Country
United States
Exchange
--
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Read More